By Matthew Brady 
Japanese AI solutions developer Recursive Inc. has signed an MoU with Saudi medical research institution King Abdullah International Medical Research Center (KAIMRC) to co-develop an advanced AI system for the early screening of tuberculosis (TB).
The collaboration will leverage chest X-ray imaging data to enhance early screening and detection of TB, with the aim of facilitating timely diagnosis and treatment, reducing the risk of mortality and preventing further transmission. The project’s scalable model is intended for deployment not only within Saudi Arabia but also in other regions with high TB burdens. Additionally, the partnership aims to expand its scope to address other infectious diseases in the future.
Saudi Arabia aims to decrease TB mortality and incidence rates by 95% and 90%, respectively, under the National Tuberculosis Program. The Kingdom is additionally pursuing an ambitious agenda for transforming the nation’s healthcare infrastructure through Saudi Vision 2030.
The partnership was formalised during the Riyadh Global Medical Biotechnology Summit organised by Saudi Arabia’s Ministry of National Guard-Health Affairs, a nationwide healthcare system with specialised hospitals and transplant centers and a network of primary to tertiary care hospitals across Saudi Arabia,
